Clinical Trials Logo

Allergy clinical trials

View clinical trials related to Allergy.

Filter by:

NCT ID: NCT04268901 Recruiting - Pain Clinical Trials

VR to Reduce Pain/Anxiety During Painful Procedures

Start date: February 19, 2016
Phase: N/A
Study type: Interventional

This study aims to test the effectiveness of virtual reality (VR) as a non-pharmaceutical intervention to reduce pain and anxiety in children undergoing painful procedures in Phlebotomy, Radiology, Infusion, Orthopedics, Gastroenterology, and Immunology, amongst others, at CHLA, as measured by self- and proxy-report. Examples of the painful procedures include IV sticks, cast removals, allergy testing, and anorectal manometries.

NCT ID: NCT04215783 Active, not recruiting - Allergy Clinical Trials

Childhood Allergy and the Neonatal Environment

CANOE
Start date: March 4, 2020
Phase:
Study type: Observational

The purpose of this research study is to study the relationship between childhood asthma, allergies, and early-life environmental factors that may cause childhood asthma and allergies. Previous birth cohort studies have found early-life environmental factors such as allergies, pollutants, viruses and bacteria have all contributed to the development of asthma and allergies. Investigators are doing this research because there continues to be a strong need to understand the root causes of asthma and allergies. The CANOE study is an observational cohort study, which means investigators are not asking participants or participant's child to change their medications and investigators will not be giving participants or participant's child a study drug.

NCT ID: NCT04186949 Completed - Asthma Clinical Trials

Early Origins of Allergy and Asthma

ARIES
Start date: October 9, 2018
Phase:
Study type: Observational

Birth cohort study with recruitment during pregnancy to determine prenatal and perinatal conditions, as well as genetic and epigenetic factors, that participate in the early setting of immune responses, and the role of these in the later determination of the risk of allergic diseases, asthma, and metabolic conditions in the offspring.

NCT ID: NCT04181632 Completed - Allergy Clinical Trials

Evaluation of Pain Alleviating Strategies During Allergy Shots

PPAST
Start date: May 20, 2019
Phase: N/A
Study type: Interventional

Subcutaneous Immunotherapy (allergy injections) is a potentially disease-modifying therapy that is effective for the treatment of allergic rhinitis/conjunctivitis, allergic asthma and stinging insect hypersensitivity. Pain, which results from the irritation of nearby nerves is a common concern of patients, particularly in children, during or after the injections. This can be a stressful and negative experience for the children. There are various techniques available to minimize pain in general. However, there is a lack of published research on how to use these techniques in children receiving allergy injections. The purpose of this study is to evaluate and compare the efficacy of the standard of care method (Ethyl Chloride/Pain Ease Spray) and three non-pharmacological pain control devices (Buzzy Bee® I, Buzzy Bee II and Shot Blocke®r) in decreasing the perception of pain during subcutaneous allergy injection in a pediatric allergy/immunology clinic setting.

NCT ID: NCT04126096 Completed - Allergy Clinical Trials

Negative Predictive Value and NIC of Beta-Lactam Antibiotics.

Start date: September 20, 2019
Phase: N/A
Study type: Interventional

The researchers are trying to evaluate how much medication is required for allergy skin testing and to determine the likelihood that patients with a negative test truly don't have an allergy to the tested drug of skin testing to commonly used antibiotics.

NCT ID: NCT04125888 Completed - Allergy Clinical Trials

Impact of AIT on Allergic Rhinitis and Asthma

Start date: July 22, 2019
Phase:
Study type: Observational

The study will assess the effectiveness of AIT treatment in real clinical practice in Germany.

NCT ID: NCT04125420 Completed - Allergy Clinical Trials

Hypersensitivity Reactions During Anesthesia

Start date: August 3, 2018
Phase:
Study type: Observational

Researchers are trying to study the natural history of allergic reactions during anesthesia and its causes and risk factors.

NCT ID: NCT04071821 Not yet recruiting - Allergy Clinical Trials

Relative Bioavailability Study to Evaluate Cetirizine HCl Gummy 10 mg and Cetirizine HCl Oral Tablets 10 mg

Start date: May 1, 2025
Phase: Phase 1
Study type: Interventional

A Randomized, Open-Label, Single-Dose, Five-Period Crossover, Relative Bioavailability Study to Evaluate Cetirizine HCl Gummy 10 mg and Cetirizine HCl Oral Tablets 10 mg Administered in Healthy Adult Male and Female Subjects

NCT ID: NCT04046731 Completed - Allergy Clinical Trials

Neuromuscular Blocking Agents Utilized During Perioperative Hypersensitivity Evaluation

Start date: September 20, 2019
Phase: N/A
Study type: Interventional

The researchers are trying to develop an allergy skin test to help predict allergic responses to medications commonly given to patients during surgery.

NCT ID: NCT04004351 Completed - Allergy Clinical Trials

Treatment Modalities in Children and Adolescents Suffering From HDM-induced Allergic Rhinitis and/or Asthma

PROTECT
Start date: September 16, 2013
Phase:
Study type: Observational

Two-stage, prospective, observational, real-world study of HDM-SLIT-naïve children (aged 5-11) and adolescents (aged 12-17) consulting allergists or other specialist physicians in France for an HDM-induced allergy. Physician- and/or patient-reported data on clinical symptoms, sensitization, patient profiles, symptom burdens, patient-physician dialogue, HDM SLIT regimens, and effectiveness were recorded on inclusion, and then again 6 to 12 months after the prescription of an HDM SLIT solution. The study's primary objective was to describe treatment modalities in children (aged from 5 to 11) and adolescents (aged from 12 to 17) with suspected HDM-induced AR or allergic asthma consulting an allergist or another specialist physician in France.